These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 4907560)

  • 21. [10 years of L-DOPA therapy of Parkinson's syndrome].
    Birkmayer W
    Wien Klin Wochenschr; 1971 Apr; 83(13):221-7. PubMed ID: 4254333
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies of amines in the striatum in monkeys with nigral lesions. The disposition, biosynthesis and metabolites of [3H]dopamine and [14C]serotonin in the striatum.
    Goldstein M; Anagnoste B; Battista AF; Owen WS; Nakatani S
    J Neurochem; 1969 Apr; 16(4):645-53. PubMed ID: 4976670
    [No Abstract]   [Full Text] [Related]  

  • 23. Enzymes of dopa metabolism of diencephalic structures in man and rabbit with special regard to extrapyramidal disorders.
    Metzel E; Riechert T; Stracke D
    Confin Neurol; 1970; 32(2):144-8. PubMed ID: 5502845
    [No Abstract]   [Full Text] [Related]  

  • 24. Modification of Parkinsonism--chronic treatment with L-dopa.
    Cotzias GC; Papavasiliou PS; Gellene R
    N Engl J Med; 1969 Feb; 280(7):337-45. PubMed ID: 4178641
    [No Abstract]   [Full Text] [Related]  

  • 25. Analysis of L-dopa induced dyskinesias in 51 patients with Parkinsonism.
    Mones RJ; Elizan TS; Siegel GJ
    J Neurol Neurosurg Psychiatry; 1971 Dec; 34(6):668-73. PubMed ID: 5158780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in the treatment of Parkinsonism with drugs.
    Rinne UK
    Acta Neurol Scand Suppl; 1972; 51():59-103. PubMed ID: 4576076
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug-induced changes in brain dopamine and their relation to parkinsonism.
    Vogt M
    Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of Parkinson's disease with L-dopa and with a combination of L-dopa and dopa-decarboxylase inhibitor].
    Agnoli A; Casacchia M; Reitano M; Ruggieri S; Barba C; Zamponi A
    Minerva Med; 1972 Dec; 63(89):4853-61. PubMed ID: 4566743
    [No Abstract]   [Full Text] [Related]  

  • 29. Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitor.
    Rinne UK; Sonninen V
    Arch Neurol; 1973 Feb; 28(2):107-10. PubMed ID: 4683147
    [No Abstract]   [Full Text] [Related]  

  • 30. Levodopa in Parkinsonism.
    Weiss JL; Chase TN
    Drugs; 1971; 2(4):257-61. PubMed ID: 4948349
    [No Abstract]   [Full Text] [Related]  

  • 31. Dopamine: stimulation-induced release from central neurons.
    Ng KY; Chase TN; Colburn RW; Kopin IJ
    Science; 1971 Apr; 172(3982):487-9. PubMed ID: 5550505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyrosine hydroxylase deficiency. A unifying concept of Parkinsonism.
    Martin WE
    Lancet; 1971 May; 1(7708):1050-1. PubMed ID: 4102972
    [No Abstract]   [Full Text] [Related]  

  • 33. [Current treatment of Parkinson syndrome with L-dopa].
    Gerstendbrand F; Gründig E; Musiol A
    Pol Tyg Lek; 1972 May; 27(21):798-800. PubMed ID: 4555002
    [No Abstract]   [Full Text] [Related]  

  • 34. [Dopaminergic conception of Parkinsonism and its treatment with L-DOPA].
    Levin SL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(9):1418-26. PubMed ID: 4349303
    [No Abstract]   [Full Text] [Related]  

  • 35. L-dopa in Parkinson's syndrome.
    Poskanzer DC
    N Engl J Med; 1969 Feb; 280(7):382-3. PubMed ID: 5764823
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypotension caused by L-dopa.
    Calne DB; Brennan J; Spiers AS; Stern GM
    Br Med J; 1970 Feb; 1(5694):474-5. PubMed ID: 4907812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
    [No Abstract]   [Full Text] [Related]  

  • 38. Parkinsonism, levodopa, and anesthesia.
    Ngai SH
    Anesthesiology; 1972 Sep; 37(3):344-51. PubMed ID: 4559395
    [No Abstract]   [Full Text] [Related]  

  • 39. L-Dopa treatment in Parkinson's Disease.
    Rinne UK; Sonninen V; Siirtola T
    Eur Neurol; 1970; 4(6):348-69. PubMed ID: 4932969
    [No Abstract]   [Full Text] [Related]  

  • 40. L-dopa in Parkinsonism. A possible mechanism of action.
    Ng LK; Chase TN; Colburn RW; Kopin IJ
    Neurology; 1972 Jul; 22(7):688-96. PubMed ID: 4673250
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.